update: Medicare will pay for Avastin off label

Despite the pros and cons presented for extending the FDA’s approval of Avastin®, Medicare announced that it will continue to pay for Avastin as off-label treatment for breast cancer.

Whether or not this influences the private insurance companies to follow a similar path is yet to be seen. In the meantime, for now patients under Medicare can relax a bit knowing that Medicare will not not pull coverage of this treatment. If it were to consider withdrawing support, it would require a lengthy process that would also require input from the public. In other words, we will hear about the proposal well in advance to respond.

Medicare will pay for Avastin in treating breast cancer. By Andrew Pollack, The New York Times 7/1/11

5 6 7 8
© 2004–2011 Donna Peach. All rights reserved.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s